Lv711
5005 积分 2021-03-15 加入
How I individualize selection of JAK inhibitors for patients with myelofibrosis
7天前
已完结
How I individualize selection of JAK inhibitors for patients with myelofibrosis
7天前
已关闭
The present and future for CAR-T cell therapy in adult B-cell ALL
18天前
已完结
The present and future for CAR-T cell therapy in adult B-cell ALL
18天前
已关闭
The high-grade B-cell lymphomas: Double hit and more
21天前
已完结
The high-grade B-cell lymphomas: Double hit and more
21天前
已关闭
Enhancing outcomes of childhood acute lymphoblastic leukemia in workplace diversity in Thailand: multicenter study on behalf of the Thai Pediatric Oncology Group
21天前
已完结
Immune checkpoints PD1/PDL1, TIM3/GAL9 and key immune mediators landscape reveal differential expression dynamics on imatinib response in chronic myeloid leukemia
21天前
已完结
CAR T Cells and T-Cell Therapies for Cancer
21天前
已完结
How I Treat on Infant Acute Lymphoblastic Leukemia
23天前
已完结
皖公网安备34019202002308
